Literature DB >> 22205444

Lung neovascularity in pulmonary arterial hypertension associated with congenital heart defects and idiopathic pulmonary arterial hypertension: study of 198 patients.

Cecilia Modolon1, Domenico Attinà, Francesco Buia, Fiorella De Luca, Patrizia Fughelli, Maria Letizia Bacchi Reggiani, Massimiliano Palazzini, Alessandra Manes, Enri Leci, Nazzareno Galiè, Maurizio Zompatori.   

Abstract

OBJECTIVES: To correlate the severity of lung neovascularity (Sheehan vessels) with the cause and haemodynamic severity of pulmonary arterial hypertension (PAH), pulmonary artery (PA) size and heart disease type in patients with PH associated with congenital heart diseases (PAH-CHD) and idiopathic PH (IPAH).
METHODS: We reviewed the HRCT and CT pulmonary angiography studies of 87 patients with PAH-CHD and 111 with IPAH; all had undergone right heart catheterisation. We evaluated the PA size and severity of neovascularity on CT.
RESULTS: Neovascularity, which was found in 72% of PAH-CHD (56% with Eisenmenger's syndrome) and in 22% of IPAH patients, is significantly related to the severity of PH and all patients with severe neovascularity had intermediate or high PH. All PAH-CHD patients had a dilated PA with a greater risk of developing severe dilatation (diameter >5 cm). The neovascularity correlated with the PA size only in IPAH.
CONCLUSIONS: Neovascularity even if not pathognomonic for PAH-CHD, is significantly more common in these patients, especially in Eisenmenger's syndrome. It is often the first CT sign to indicate the severity of PH in PAH-CHD and IPAH. A neovascularity ≥5 on CT indicates a intermediate or high PH. KEY POINTS: • Large retrospective studying specific lung disorders in patients with pulmonary arterial hypertension. • Neovascularity is often the first CT sign indicating the severity of pulmonary hypertension Alterations of lung parenchyma on CT in pulmonary hypertension are described • The first study to assess the severity of pulmonary hypertension by CT • If substantiated, CT might eventually replace some cardiac catheterisation for evaluating PH.

Entities:  

Mesh:

Year:  2011        PMID: 22205444     DOI: 10.1007/s00330-011-2347-4

Source DB:  PubMed          Journal:  Eur Radiol        ISSN: 0938-7994            Impact factor:   5.315


  15 in total

1.  Pulmonary hypertension and left heart function: insights from tissue Doppler imaging and myocardial performance index.

Authors:  Shu-Mei Chang; Chiung-Chih Lin; Shih-Hung Hsiao; Chiu-Yen Lee; Shu-Hsin Yang; Shih-Kai Lin; Wei-Chen Huang
Journal:  Echocardiography       Date:  2007-04       Impact factor: 1.724

Review 2.  Pulmonary arterial pressure during rest and exercise in healthy subjects: a systematic review.

Authors:  G Kovacs; A Berghold; S Scheidl; H Olschewski
Journal:  Eur Respir J       Date:  2009-03-26       Impact factor: 16.671

3.  Relationship between pulmonary artery diameter at computed tomography and pulmonary artery pressures at right-sided heart catheterization. Massachusetts General Hospital Lung Transplantation Program.

Authors:  J B Haimovici; B Trotman-Dickenson; E F Halpern; G W Dec; L C Ginns; J A Shepard; T C McLoud
Journal:  Acad Radiol       Date:  1997-05       Impact factor: 3.173

Review 4.  From the archives of the AFIP: pulmonary vasculature: hypertension and infarction.

Authors:  A A Frazier; J R Galvin; T J Franks; M L Rosado-De-Christenson
Journal:  Radiographics       Date:  2000 Mar-Apr       Impact factor: 5.333

5.  A CT sign of chronic pulmonary arterial hypertension: the ratio of main pulmonary artery to aortic diameter.

Authors:  C S Ng; A U Wells; S P Padley
Journal:  J Thorac Imaging       Date:  1999-10       Impact factor: 3.000

6.  High-resolution chest CT findings do not predict the presence of pulmonary hypertension in advanced idiopathic pulmonary fibrosis.

Authors:  David A Zisman; Arun S Karlamangla; David J Ross; Michael P Keane; John A Belperio; Rajan Saggar; Joseph P Lynch; Abbas Ardehali; Jonathan Goldin
Journal:  Chest       Date:  2007-06-15       Impact factor: 9.410

7.  Proximal pulmonary arterial and intrapulmonary radiologic features of Eisenmenger syndrome and primary pulmonary hypertension.

Authors:  Joseph K Perloff; Eric M Hart; S Melanie Greaves; Pamela D Miner; John S Child
Journal:  Am J Cardiol       Date:  2003-07-15       Impact factor: 2.778

8.  Guidelines for the diagnosis and treatment of pulmonary hypertension: the Task Force for the Diagnosis and Treatment of Pulmonary Hypertension of the European Society of Cardiology (ESC) and the European Respiratory Society (ERS), endorsed by the International Society of Heart and Lung Transplantation (ISHLT).

Authors:  Nazzareno Galiè; Marius M Hoeper; Marc Humbert; Adam Torbicki; Jean-Luc Vachiery; Joan Albert Barbera; Maurice Beghetti; Paul Corris; Sean Gaine; J Simon Gibbs; Miguel Angel Gomez-Sanchez; Guillaume Jondeau; Walter Klepetko; Christian Opitz; Andrew Peacock; Lewis Rubin; Michael Zellweger; Gerald Simonneau
Journal:  Eur Heart J       Date:  2009-08-27       Impact factor: 29.983

9.  Eisenmenger syndrome and idiopathic pulmonary arterial hypertension: do parenchymal lung changes reflect aetiology?

Authors:  N Griffin; D Allen; J Wort; M Rubens; S Padley
Journal:  Clin Radiol       Date:  2007-04-05       Impact factor: 2.350

10.  Mechanisms of improved arterial oxygenation after peripheral chemoreceptor stimulation during hypoxic exercise.

Authors:  R Naeije; C Mélot; G Niset; M Delcroix; P D Wagner
Journal:  J Appl Physiol (1985)       Date:  1993-04
View more
  2 in total

1.  Lung perfusion characteristics in pulmonary arterial hypertension (PAH) and peripheral forms of chronic thromboembolic pulmonary hypertension (pCTEPH): Dual-energy CT experience in 31 patients.

Authors:  Jessica Giordano; Suonita Khung; Alain Duhamel; Claude Hossein-Foucher; Dimitri Bellèvre; Nicolas Lamblin; Jacques Remy; Martine Remy-Jardin
Journal:  Eur Radiol       Date:  2016-08-01       Impact factor: 5.315

Review 2.  Thoracic manifestation of Eisenmenger's syndrome in adult patients: a MDCT review.

Authors:  Domenico Attinà; Fabio Niro; Giorgio Garzillo; Cecilia Modolon; Vincenzo Russo; Luigi Lovato; Nazareno Galiè; Maurizio Zompatori
Journal:  Lung       Date:  2014-12-31       Impact factor: 2.584

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.